Panomics
Latest round
- Series C
Last raised
- Feb 2006
Total raised
- $56M
Investors
- 14
About Panomics
Panomics, Inc.Panomics, Inc. is a biotechnology company based in Fremont, US, that focuses on molecular biology and gene expression analysis. Founded by Radu Tanasa, who has a background in biotechnology innovation, the company has undergone significant changes in its operational strategy over time. In November 2008, Panomics was acquired by Affymetrix for USD 73 mn, marking a pivotal moment in its history as it shifted to become part of a larger organization.Panomics specializes in advanced molecular biology tools and technologies, focusing primarily on gene expression analysis and protein quantification. Their core offerings include proprietary multiplex biomarker assays that allow researchers to analyze multiple targets simultaneously in a single sample. These products are designed to enhance the efficiency and accuracy of research in fields such as drug discovery, disease biomarker identification, and clinical diagnostics. The company serves a diverse client base, which includes academic research institutions, pharmaceutical companies, and biotechnology firms, primarily in North America and Europe.Panomics generates revenue through a combination of direct sales of its assay kits and consumables alongside potential collaborative agreements with research institutions and pharmaceutical firms. The business model typically involves B2B transactions, where clients purchase products as part of their research initiatives. Transactions are structured around subscription services for recurring access to new assay developments and updates, as well as one-time purchases of their flagship products. Pricing plans for these products are tiered based on volume and specific configurations, catering to the varying needs of different research entities.In the future, Panomics plans to continue expanding its product offerings with new assays designed to enhance research in personalized medicine, although specific release dates have not been detailed. The company is also focusing on expanding its market reach into additional geographical regions, particularly in Europe, aiming for a broader footprint by 2025.
Who invested in Panomics
14 investors across 4 rounds
See all investors in Panomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Panomics
Who invested in Panomics?
Panomics has 14 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Panomics raised?
Panomics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Panomics last raise money?
Panomics's most recent round on record is a Series C, in Feb 2006.
What does Panomics do?
Panomics is a biotechnology company.
Where is Panomics headquartered?
Panomics is headquartered in Fremont, US.
Which VCs invest in companies like Panomics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Panomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Panomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.